Immunogenic composition

Details for Australian Patent Application No. 2003278166 (hide)

Owner GlaxoSmithKline Biologicals s.a.

Inventors Stephenne, Jean; Mayeresse, Yves

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003278166

PCT Number PCT/EP03/12160

PCT Pub. Number WO2004/039399

Priority 0225543.8 01.11.02 GB; 0317380.4 24.07.03 GB; 0225520.6 01.11.02 GB; 0225532.1 01.11.02 GB; 0317371.3 24.07.03 GB; 0317381.2 24.07.03 GB

Filing date 30 October 2003

Wipo publication date 25 May 2004

Acceptance publication date 29 January 2009

International Classifications

A61K 39/13 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

26 February 2004 Complete Application Filed

  Priority application(s): 0225543.8 01.11.02 GB; 0317380.4 24.07.03 GB; 0225520.6 01.11.02 GB; 0225532.1 01.11.02 GB; 0317371.3 24.07.03 GB; 0317381.2 24.07.03 GB

24 June 2004 Application Open to Public Inspection

  Published as AU-B-2003278166

29 January 2009 Application Accepted

  Published as AU-B-2003278166

28 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003278167-Heat transfer fluids for application over a broad range of temperatures

2003278165-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN ENDOTHELIAL DIFFERENTIATION, LYSOPHOSPHATIDIC ACID G-PROTEIN-COUPLED RECEPTOR 2 (EDG2)